Delivery Order SPE2DB22D2206-SPE2DB25FJN85
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $8.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) under a firm fixed-price contract valued at $27,672.52. This delivery order is expected to be completed by August 20, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen Drug Corp's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 50 mg capsules (120 count) at a firm fixed price of $13,836.26. This is a non-set-aside contract with an ultimate completion date of September 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a purchase under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order to AmerisourceBergen Drug Corporation for the supply of 4,565,810 units of the pharmaceutical product Tafinlar 75 mg capsules. The order has an ultimate completion date of October 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a range...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a leading pharmaceutical sourcing and distribution company, to provide 120 capsules of the brand name cancer drug Tafinlar. The delivery order has a ceiling value of $16,278.68 and a period of performance through April 23, 2024. AmerisourceBergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication, to be delivered to a facility in Conshohocken, Pennsylvania by September 11, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order from its corporate headquarters using its extensive distribution network to rapidly deliver this critical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the cancer medication Tafinlar (50 mg capsules). The contract has a firm fixed price of $30,424.90 and a performance period ending on May 22, 2025. It is not a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $8,139.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 120 count capsules of the oncology medication TAFINLAR 75 mg. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of Tafinlar 50 mg capsules, a prescription medication, with a ceiling value of $6,313.86 and an ultimate completion date of October 28, 2024. The contract is a firm-fixed-price delivery order, and there is no set-aside designation. As one of the largest pharmaceutical distributors in the United States,...
- The Defense Logistics Agency awarded a $7,940.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 120 capsules of Tafinlar, a cancer treatment medication. As the prime contractor, Amerisourcebergen will fulfill the order from its facility in Conshohocken, Pennsylvania by October 13, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to ensure medical supplies are available to support military readiness and...